Medicina

Medicine & Life Sciences

1. Mesenchymal Stem Cells 100%
2. Chile 71%
3. Bipolar Disorder 41%
4. Extracellular Vesicles 39%
5. Exosomes 35%
6. Pregnancy 29%
7. Stem Cells 28%
8. Pre-Eclampsia 25%
9. Cell- and Tissue-Based Therapy 24%
10. Post-Synaptic Density 21%
11. Vaccines 20%
12. Serogroup 20%
13. Mothers 20%
14. Vaccination 17%
15. Therapeutics 17%
16. Mortality 16%
17. Regulatory T-Lymphocytes 16%
18. T-Lymphocytes 16%
19. Gestational Diabetes 16%
20. MicroRNAs 15%
21. Meningococcal Infections 15%
22. Biomarkers 15%
23. Th17 Cells 14%
24. Kidney 14%
25. Gingival Crevicular Fluid 13%
26. Pregnant Women 13%
27. Child 13%
28. Proteins 13%
29. Peroxisome Proliferator-Activated Receptors 13%
30. Fluoxetine 13%
31. Fetal Growth Retardation 12%
32. Latin America 12%
33. Phenotype 12%
34. Immunosuppressive Agents 12%
35. Health 12%
36. Astrocytes 12%
37. Mitochondria 12%
38. Pneumococcal Infections 12%
39. Regeneration 12%
40. Coronavirus 11%
41. Periodontitis 11%
42. Neuropilin-1 11%
43. SARS Virus 11%
44. Renal Dialysis 11%
45. Systemic Lupus Erythematosus 10%
46. Rheumatoid Arthritis 10%
47. Macrophages 10%
48. 10-valent pneumococcal conjugate vaccine 10%
49. First Pregnancy Trimester 10%
50. Pneumococcal Vaccines 10%
51. Placenta 9%
52. Seizures 9%
53. Population 9%
54. Peritoneal Dialysis 9%
55. Neurons 9%
56. Safety 9%
57. Antidepressive Agents 9%
58. Obesity 9%
59. acylaminoacyl-peptidase 9%
60. Meta-Analysis 8%
61. Immunization Programs 8%
62. Immunization 8%
63. In Vitro Techniques 8%
64. Neuronal Plasticity 8%
65. Conjugate Vaccines 8%
66. Umbilical Cord 8%
67. Communicable Diseases 8%
68. Cohort Studies 8%
69. Adult Respiratory Distress Syndrome 7%
70. Spironolactone 7%
71. Reperfusion Injury 7%
72. Prosencephalon 7%
73. Inflammation 7%
74. Brain 7%
75. Pneumonia 7%
76. Neisseria meningitidis 7%
77. Autoimmune Experimental Encephalomyelitis 7%
78. Case-Control Studies 7%
79. Blood Vessels 7%
80. Neural Stem Cells 7%
81. Synapses 7%
82. Transplantation Tolerance 7%
83. NFATC Transcription Factors 7%
84. Regenerative Endodontics 7%
85. Incidence 7%
86. Neurogenesis 7%
87. Cold Temperature 7%
88. Randomized Controlled Trials 7%
89. N-Methyl-D-Aspartate Receptors 7%
90. Depression 7%
91. Gestational Age 7%
92. Kainic Acid 7%
93. Acute Kidney Injury 7%
94. Hypertension 6%
95. Chronic Renal Insufficiency 6%
96. Hypoxia 6%
97. Confidence Intervals 6%
98. Fetus 6%
99. Cost-Benefit Analysis 6%
100. Ischemia 6%